Mumbai: Pharma major, Sun Pharmaceutical, is gearing up to introduce its experimental anti-obesity and type 2 diabetes ...

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

At the Womenpreneur Awards 2025, Fonzie was honoured as the Fragrance Partner. Ishita Mishra is the founder of Fonzie, a ...

“We are also keenly looking at it," Majumdar, who leads the company’s specialty division out of Mumbai, said ... Innovator Eli Lilly, whose weight loss drug Tirzepatide is sold under brand ...

And they represent every vertical and horizontal one can think of—from the large financial companies, with their massive centres, to drug companies such as Novo Nordisk and Eli Lilly—which has ...

These include AstraZeneca, Eli Lilly, Roche, Johnson & Johnson ... In September 2024, Pfizer set up a captive unit in Mumbai for healthcare-related analytics tasks. According to a recent Nasscom ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...